Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets
Diseases · 27.04.2026 · 14 (5) · 153
DOI: 10.3390/diseases14050153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases, online erschienen am 27.04.2026. Verfasst von Teresa Smit und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical and Translational Research Unit (CTRU) of the Medical Oncology Centre of Rosebank, Saxonwold, Johannesburg 2196, South Africa. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche (South Africa), The Medical Oncology Centre of Rosebank, University of Pretoria.
Abstract (Originalsprache)
Background/objectives: Although informative, current insights into the inflammatory nature of colorectal cancer (CRC) have yet to have a meaningful impact on the prevention of, and development of novel therapies for, the treatment of this prevalent and challenging disease. Accordingly, the current study was focused on identifying putative, key, systemic, mostly pro-inflammatory biomarkers of metastatic CRC (mCRC) prognosis and outcome.
Methods
Patients with mCRC (n = 38) and matched healthy controls (n = 30) were recruited to the study. A multiplex magnetic bead array system and an ELISA procedure were used to measure the plasma concentrations of selected cytokines (n = 25) and that of C-reactive protein (CRP) by immunonephelometry. Systemic inflammatory indices (n = 5) were derived from the hematological data.
Results
Plasma levels of 17/25 of the cytokine biomarkers and CRP were found to be significantly elevated, while the neutrophil/lymphocyte ratio proved to be the most useful of the various inflammatory indices. Subgroup analysis of the data derived from the group of mCRC patients revealed that the intensity of the systemic inflammatory response was mostly unaffected by tumor location, age, gender, and treatment line. The exception was time to progression, with a shorter time (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Clinical and Translational Research Unit (CTRU) of the Medical Oncology Centre of Rosebank, Saxonwold, Johannesburg 2196, South Africa.
- Department of Immunology, Faculty of Health Sciences, University of Pretoria, Prinshof, Pretoria 0083, South Africa.
- Centre for Innovative Immunology Research and Education (IINSPIRE), Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Pretoria, Prinshof, Pretoria 0083, South Africa.
ORCID-Profile: Helen C Steel, Theresa M Rossouw
Förderung
- Roche (South Africa)
- The Medical Oncology Centre of Rosebank
- University of Pretoria
Zitieren
APA
Smit, T., Anderson, R., Steel, H. C., Rossouw, T. M., & Rapoport, B. L. (2026). Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets. Diseases, 14(5), 153. https://doi.org/10.3390/diseases14050153
Vancouver
Smit T, Anderson R, Steel HC, Rossouw TM, Rapoport BL. Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets. Diseases. 2026;14(5):153. doi:10.3390/diseases14050153
BibTeX
@article{Smit2026,
author = {Smit, Teresa and Anderson, Ronald and Steel, Helen C and Rossouw, Theresa M and Rapoport, Bernardo L},
title = {Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets},
journal = {Diseases},
year = {2026},
volume = {14},
number = {5},
pages = {153},
doi = {10.3390/diseases14050153}
}
EUVIMED